CORK, Ireland, November 27, 2014 /PRNewswire/ --
Hovione announced today it has filed its first Investigational New Drug (IND) Application with the U.S. Food and Drug Administration (FDA). This event represents a milestone in Hovione's strategy of developing improved drug delivery...